List of Akston Biosciences Corporation patents

List of Akston Biosciences Corporation patents

List of Rohm (company) patents

List of Dominion Energy patents

List of Live Nation Entertainment patents

List of funding rounds for Babel Finance

List of awards received by Mateo Kovačić

Patents where

Current Assignee

Name

is

Akston Biosciences Corporation

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10961294 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 10961294 was granted and assigned to Akston Biosciences Corporation on March, 2021 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	10961294	March 30, 2021
	‌ US Patent 10947292 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 10947292 was granted and assigned to Akston Biosciences Corporation on March, 2021 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	10947292	March 16, 2021
	‌ US Patent 11555058 Cells engineered to express ultra-long acting insulin-Fc fusion proteins		Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11555058	January 17, 2023
	‌ US Patent 11352407 Ultra-long acting insulin-Fc fusion proteins	Patent 11352407 was granted and assigned to Akston Biosciences Corporation on June, 2022 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11352407	June 7, 2022
	‌ US Patent 11359001 Insulin-Fc fusions and methods of use	Patent 11359001 was granted and assigned to Akston Biosciences Corporation on June, 2022 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11359001	June 14, 2022
	‌ US Patent 11267862 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 11267862 was granted and assigned to Akston Biosciences Corporation on March, 2022 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11267862	March 8, 2022
	‌ US Patent 11261229 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 11261229 was granted and assigned to Akston Biosciences Corporation on March, 2022 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11261229	March 1, 2022
	‌ US Patent 10851147 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 10851147 was granted and assigned to Akston Biosciences Corporation on December, 2020 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	10851147	December 1, 2020
	‌ US Patent 10870686 Ultra-long acting insulin-FC fusion proteins and methods of use	Patent 10870686 was granted and assigned to Akston Biosciences Corporation on December, 2020 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	10870686	December 22, 2020
	‌ US Patent 10597435 Insulin-Fc fusions and methods of use	Patent 10597435 was granted and assigned to Akston Biosciences Corporation on March, 2020 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	10597435	March 24, 2020
	‌ US Patent 11213581 Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use	Patent 11213581 was granted and assigned to Akston Biosciences Corporation on January, 2022 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11213581	January 4, 2022
	‌ US Patent 11198719 Ultra-long acting insulin-Fc fusion protein and methods of use	Patent 11198719 was granted and assigned to Akston Biosciences Corporation on December, 2021 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11198719	December 14, 2021
	‌ US Patent 11707517 Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use		Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11707517	July 25, 2023
	‌ US Patent 11667689 Insulin-Fc fusion proteins and methods of use to treat cancer		Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11667689	June 6, 2023
	‌ US Patent 11919935 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 11919935 was granted and assigned to Akston Biosciences Corporation on March, 2024 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11919935	March 5, 2024
	‌ US Patent 11773151 Ultra-long acting insulin-Fc fusion proteins and methods of use	Patent 11773151 was granted and assigned to Akston Biosciences Corporation on October, 2023 by the United States Patent and Trademark Office.	Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11773151	October 3, 2023
	‌ US Patent 11673934 Ultra-long acting insulin-Fc fusion proteins and methods of use		Akston Biosciences Corporation	Akston Biosciences Corporation		United States Patent and Trademark Office	11673934	June 13, 2023

17 results

0 selected

17 results

0 selected